Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Planned sale EVP, General Counsel & Sec sold 50,000 shares at an average $22.04 ($1,101,750)
  2. 4 Open-market buy Director bought 120,409 shares at $21.61 ($2,602,038)
  3. 4 Gift President and CEO gave 19,020 shares (gift)
  4. 4 Gift President and CEO gave 116,893 shares (gift)
  5. 4 Shares withheld for taxes President and CEO gave up 46,608 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP and CFO gave up 17,147 shares (to pay taxes)
  7. 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 12,560 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP, Commercial gave up 14,354 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 14,354 shares (to pay taxes)
  10. 4 Gift President and CEO gave 113,721 shares (gift)
  11. 4 Planned sale CSO/EVP Disc & Trans Research sold 4,600 shares at $22.47 ($103,362)
  12. 4 Shares withheld for taxes President and CEO gave up 303,779 shares (to pay taxes)
  13. 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 240,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes President and CEO gave up 23,304 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP and CFO gave up 8,074 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 7,177 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP, Commercial gave up 7,177 shares (to pay taxes)
  19. 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 6,280 shares (to pay taxes)
  20. 4 Open-market sale EVP and CFO sold 120,000 shares at an average $20.60 ($2,471,400)

Page 10 of 73 · 1,458 filings